Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Magnesium Loss In Patients Given Monoclonal Antibodies

02.05.2007
97% of patients with cancer treated with monoclonal antibodies—cetuximab, matuzumab, or panitumumab—that target the epidermal growth factor receptor (EGFR) have some degree of magnesium loss (hypomagnesaemia), according to a study published today in the May issue of THE LANCET ONCOLOGY.

“Our study is important because it shows that magnesium wasting will occur in all patients…[Previously,] hypomagnesaemia was thought to be restricted to an undefined subset of patients”, says lead author Prof Sabine Tejpar. “Predicting the risk of hypomagnesaemia will also be important in those patients receiving combination treatments with nephrotoxic and potential magnesium-wasting agents, such as cisplatin.”

Previous retrospective studies had shown severe magnesium loss (grades 3 and 4 hypomagnesaemia) in only a small proportion of patients given anti-EGFR drugs and whether all or a subset of patients are affected was unknown. Hypomagnesaemia is a serious side-effect of treatment as it can cause dizziness, weakness, cardiac abnormalities, or even generalised convulsions. Furthermore, agents against EGFR are being used increasingly to treat solid tumours, in particular cancers of the colorectum. However, the extent of this side-effect in patients given these antibodies has not previously been fully assessed.

Prof Sabine Tejpar and colleagues therefore studied prospectively the degree of hypomagnesaemia in 98 patients with metastatic colorectal cancer treated with these antibodies. 95 (97%) of patients had decreased serum magnesium concentrations during treatment with the EGFR-targeted antibodies compared with baseline measures (mean serum magnesium slope –0•00157 mmol/L/day [95% CI –0•00191 to –0•00123]) and this change was significantly lower than that seen in the control group not receiving antibody treatment—ie, given chemotherapy alone (0•00014 mmol/L/day [–0•00026 to 0•00055]).

In an accompanying comment, Dr Marwan Fakih (Roswell Park Cancer Institute, NY, USA) discusses the implications of the study data for clinical practice, commenting that patient characteristics, in terms of age, baseline magnesium concentrations, and duration of treatment, could help in the early identification of those at high risk. He suggests there are still a number of unanswered questions, such as whether the magnesium concentration slope could be used to predict the time at which clinically significant hypomagnesaemia will occur, and he indicates that validation of The Lancet Oncology data in a larger prospective study could help in the development of a model that accurately predicts those who are most at risk of severe hypomagnesaemia and candidates for monitoring and early intervention. In addition, Fakih proposes that intermittent treatment schedules could be appropriate for those at high risk.

The authors agree with Dr Fakih that identification of these high-risk patients is important and conclude that their study suggests a pivotal role of the EGFR-signalling pathway in regulating magnesium homeostasis: “Our study might pave the way for future therapeutic intervention to treat hypomagnesaemia and modulate or prevent its occurrence”.

Tony Kirby | alfa
Further information:
http://www.lancet.com

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>